Logotype for Renalytix Plc

Renalytix (RENX) investor relations material

Renalytix Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Renalytix Plc
Q4 2025 earnings summary4 Nov, 2025

Executive summary

  • FY2025 marked a pivotal year with Medicare reimbursement for the FDA-approved kidneyintelX.dkd test, driving a 37% increase in commercial testing volumes and 30% revenue growth year-over-year.

  • Strategic partnerships with MVP Health Care and Tempus AI expanded access and distribution, reinforcing leadership in chronic kidney disease management.

  • Operational restructuring reduced administrative expenses by over 40%, and two oversubscribed capital raises provided a stable financial platform.

  • Integration with electronic medical record (EMR) systems proved effective for scaling adoption and simplifying physician workflows.

Financial highlights

  • Total revenue for FY2025 was $3.0 million, up from $2.3 million in FY2024; testing revenue reached $2.7 million, and pharma services revenue grew by 200% to $0.3 million.

  • Gross margin improved to 40% from 9% the previous year, driven by lab efficiencies and higher-margin service revenue.

  • Administrative expenses decreased to $18.4 million from $30.7 million, reflecting cost optimization and delisting from NASDAQ.

  • Net loss for the year was $20.4 million, a significant improvement from the $45.5 million loss in FY2024.

  • Cash on hand at year-end was $3.6 million, with $14 million raised in October 2024 and $9 million post-year-end in September 2025.

Outlook and guidance

  • Focus remains on expanding EMR integration, scaling national access, and leveraging partnerships to drive growth.

  • Expansion into Arizona as a fourth target market, representing 20% of the addressable market.

  • Additional strategic agreements and a capital markets day are planned for FY26.

Quantify EMR integration's impact on test volume
Assess the new convertible bond's financial flexibility
What gross margin is needed for cash flow positive?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Renalytix earnings date

Logotype for Renalytix Plc
H1 202618 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Renalytix earnings date

Logotype for Renalytix Plc
H1 202618 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Renalytix Plc is a diagnostics company specializing in the development of tests that assess kidney health. The company integrates machine learning and clinical data to create predictive diagnostics aimed at improving kidney disease treatment. It serves healthcare providers and institutions through strategic collaborations and commercialization efforts. Renalytix Plc is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage